Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide

Sun Pharmaceutical Industries, Inc.🇺🇸 United States

FDA Page

Effective Date: Jul 13, 2022
Approval ID: ee828a36-7f94-4106-8c4d-c61ba7e2f308
Products: 5 registered
Version: 13

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE TABLETS safely and effectively. See full prescribing information for OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE TABLETS. OLMESARTAN MEDOXOMIL AMLODIPINE AND HYDROCHLOROTHIAZIDE tablets, for oral use Initial U.S. Approval: 2010

Quick Stats

Total Products5

Labelers2

Label Sections22

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.